Products

MeCoreHub

Start with T1 today. More views are in development.

mch.engravevision.com Utilities / Link Shorteners & QR Codes

Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$5/mo
Lower than 73% of peersNiche median $9/mo
Creators
Félix Eduardo Guerra González
No social account linked
Launched
10mo ago
2026-01-27 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Hub of practical mini web tools for creators

    Jan 27 · 10mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

No traffic channel or country breakdown data for this website yet.

Search

Domain authority —Domain registered 2025-04-01

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Global subscription
$5/mo
Includes T1 today.

Trial: La prueba es de 30 días. · 1 paid tier ($5) · Observed 2026-11-07 · Pricing page

Entry price $5/mo, Lower than 73% of peers; “Link Shorteners & QR Codes” median is $9/mo.View pricing benchmark

Website snapshots

Indexed 2026-01-27

Key pages

Desktop & mobile archive
mch.engravevision.com/ Snapshot 2026-11-07

Questions & evidence

How much does MeCoreHub cost?
Global subscription: $5/mo. Observed 2026-11-07. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does MeCoreHub get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is MeCoreHub and what platforms does it support?
MeCoreHub is catalogued under Link Shorteners & QR Codes: Start with T1 today. More views are in development. Supported platforms: Web.

Related products in this category

Utilities / Link Shorteners & QR Codes

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.